Plain-English translation of NCT07276438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT). The study compares two types of SBRT: one that uses the same treatment plan every day, and one that adjusts the treatment plan daily based on real-time imaging to match the exact size and position of your prostate. Researchers want to see if the daily-adjusted approach reduces side effects, especially urinary problems, while treating your cancer effectively.
Prostate radiation therapy can cause uncomfortable side effects like urinary problems and bowel issues. By adjusting the treatment plan each day based on real-time imaging, doctors may be able to reduce radiation dose to healthy tissues around the prostate, potentially reducing these side effects while still effectively treating the cancer.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard radiation therapy or daily-adjusted radiation therapy. Either way, you will receive 5 radiation treatments over about 18 days, given either every other day or daily. Before treatment starts and throughout the study, you will have MRI or CT scans and blood tests. After your treatments end, you will have follow-up visits at 1, 3, 6, 9, 12, and 24 months to check for side effects and monitor how well the treatment worked.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States